Stay updated on Dolutegravir Plus NRTIs in HIV-2 Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.

Latest updates to the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page
- Check3 days agoChange DetectedFooter metadata updated to Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, and this change does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedPublications section text now states that publications are automatically populated from PubMed and may not pertain to the study. A Revision: v3.3.2 tag was added, replacing the previous v3.2.0.SummaryDifference0.1%

- Check40 days agoChange DetectedThe government funding lapse notice about data currency and site operations has been removed, and the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedThe update appears to be formatting/layout adjustments on the Study Details page without modifying core content (e.g., eligibility criteria, outcome measures, or study status). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedCore content updated with a government funding notice and the NIH Clinical Center operating status, plus a version bump to v3.2.0.SummaryDifference3%

- Check90 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.1%

Stay in the know with updates to Dolutegravir Plus NRTIs in HIV-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.